robert henric

robert henric

Followers 19
Following 19
The report “Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) – Forecast”, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the ANA testing market, along with revenue estimates & forecasts and market share analysis.The Global Antinuclear Antibody Testing Market is expected to reach USD 1,476.1 Million, at a CAGR of 12.4%.The increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide are the major factors driving the growth of this market.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=218189007Market Segmentation in Detailed:Based on Products, the ANA testing market is segmented into assay kits & reagents, systems, and software & services.The assay kits & reagents segment is expected to account for the largest share of the global market, primarily due to the growing number of reagent rental agreements and increasing prevalence of autoimmune diseases worldwide.The Antinuclear Antibody Test Market is segmented into five major disease segments, namely, rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome, scleroderma, and other diseases.Other diseases include Raynaud’s Syndrome, polymyositis, mixed connective tissue disease, drug-induced lupus, and autoimmune hepatitis.The rheumatoid arthritis segment is expected to account for the largest share of this market primarily due to the increasing incidence of rheumatoid arthritis.Based on techniques, the ANA testing market is segmented into enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and multiplex assay.The ELISA segment is expected to account for the largest share of this market majorly due to the expanding applications of ANA in autoimmune disease testing and therapeutic drug level monitoring.Geographical View in-detailed:The global antinuclear antibody test market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW).
1
The report “Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region – Global Forecast to 2024″, the Cardiac Mapping System Market is expected to reach USD 2.1 billion by 2024 from USD 1.4 billion in 2019, at a CAGR of 8.7%.The Growth in the cardiac mapping industry is driven primarily by factors such as new entrants in the market, growing investments, funds, and grants, increasing incidence of target diseases, and growth in the geriatric population.Market Size Estimation;Both top-down and bottom-up approaches were used to estimate and validate the total size of the cardiac mapping market.The research methodology used to estimate the market size includes the following:– The key players in the industry and markets have been identified through extensive secondary research– The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes– All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sourcesRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=89853405Atrial fibrillation is the primary application areas of the global cardiac mapping marketThe market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias.The atrial fibrillation segment estimated to command the largest share of the market in 2019, and this segment is also projected to register the highest CAGR owing to the rise in incidences of AF worldwide and the subsequent increase in the ablation procedures.Geographical View in-detailed:North America held the largest share of the market in 2019 and is projected to continue to do so during the forecast period.Factors such as the increase in approval rate of mapping systems and clinical trials validating cardiac mapping systems in the US, high incidence of CVDs, growing focus of government organizations on providing funding for research, and increasing geriatric population in Canada are driving the North American cardiac mapping market.Key Market Players;The major vendors in the cardiac mapping market include Biosense Webster (US), Abbott (US), and Boston Scientific Corporation (US).These leading players offer a strong suit of products for cardiac mapping and have a broad geographic presence.The other players in this market include Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System (Germany).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89853405Biosense Webster (US) held the dominant position in the cardiac mapping market in 2018.
The report “Protein Crystallization and Crystallography Market by Technology (NMR, X-Ray Crystallography), Product & Service (Instrument (Liquid Handling (Automated)), Consumable (Reagent, Microplate) End User, and Region – Global Forecast to 2025″, the Protein Crystallization Market is projected to reach USD 1.7 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 8.9% during the forecast period.Protein Crystallization & Crystallography Market and Top technologies :X-ray crystallography – XRC is a widely used technology for protein analysis and provides data on protein structures at the atomic level, which serves to provide a greater understanding of protein function in terms of their interaction with other molecules, the ability to undergo conformational changes and to perform catalysis in the presence of enzymes.In contrast to X-ray crystallography, NMR spectroscopy uses proteins in soluble forms.Cryo-Electron Microscopy – Cryo-electron microscopy is an emerging technology where protein samples are studied at cryogenic temperatures (the temperature of liquid nitrogen).As these studies are carried out at cryogenic temperatures, they offer various advantages.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=147057058The protein crystallization market is estimated to witness tremendous growth in the next five years as it comprises automated systems that offer very high sensitivity.In addition, protein purification, reagents/consumables, X-ray, and the crystallography segments of the crystallization of protein market are projected to see high growth rates on account of a large number of ongoing research projects in the domain.Thus, the emerging markets of Asia as well as the electrophoresis technology for protein purification are the new revenue sources for the protein crystallization market.The Americas and Europe are the established markets for protein crystallization and crystallography.The developing regions, including BRIC (Brazil, Russia, India, and China) countries, are expected to form the new revenue pockets for this market.
1
The Research Report on“Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) – Global Forecast to 2023″ published by MarketsandMarkets™, is projected to reach USD 604.9 Million, at a CAGR of 8.3% during the forecast period.The growth in this market is mainly attributed to factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and the rising demand for minimally invasive procedures.Research Methodology;Top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of various other dependent submarkets.Major players in the market were identified through secondary sources; directories; databases such as Hoovers, Bloomberg Businessweek, Factiva, and OneSource, journals and their market revenues were determined through primary and secondary research.Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives.All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=158143803Embolic Protection Devices Market Segmentation in Detailed:The neurovascular segment is expected to grow at the highest CAGR during the forecast periodOn the basis of application, categorized into cardiovascular, neurovascular, and peripheral vascular diseases.The neurovascular segment is expected to grow at the highest CAGR during the forecast period.The favorable medical reimbursement scenarios for neurovascular procedures in developed countries, increasing awareness about the clinical efficacy of embolic protection devices among neurosurgeons, and the rising adoption of these systems across developing countries (such as China and India) are expected to drive the growth of this application segment during the forecast period.The percutaneous coronary intervention segment accounted for the largest market share in 2017On the basis of indication, categorized into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications.
The Global COVID-19 Impact on Vaccines and Drugs Market study involved the extensive use of both primary and secondary sources.The research process involved the study of various factors affecting the industry to identify the key players, competitive landscape, key market dynamics, and key player strategies.The Global COVID-19 Vaccines Market is projected to reach USD 1,401 million by 2025 from USD 2,273 million in 2022, at a CAGR of -14.9% during the forecast period.The growth of the COVID vaccines market is attributed majorly to the rising number of people infected with COVID-19 and increasing funding for vaccine development.The Global COVID-19 Drugs Market is projected to reach USD 2 million by 2025 from USD 165 million in 2020, at a CAGR of -57.8% during the forecast period.The growth of the COVID drugs market is primarily attributed to use of repurposed drugs for compassionate use, and the emergence of alternative therapies such as convalescent plasma therapy which were earlier used for treating epidemic diseases such as SARS, MERS, and H1N1.Moreover, collaborations between global organizations and governments of various nations to promote the supply of essential drugs and medical supplies are fueling the market growth.Currently, the R landscape for COVID-19 vaccines includes 115 vaccine candidates.The most advanced candidates that have recently moved into clinical development are:– mRNA-1273 from Moderna– Ad5-nCoV from CanSino Biologics– INO-4800 from Inovio– LV-SMENP-DC and pathogen-specific aAPC from Shenzhen Geno-Immune Medical InstituteRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=112248051Drugs targeting COVID-19 are falling majorly in the category of repurposed drugs that have already entered phase 2 of clinical development.As the COVID-19 pandemic progresses, pharmaceutical and biotechnology companies are increasing their efforts to find a cure for the disease.In just a few weeks, scientists have found a list of molecules that target COVID-19.
1
The report “Medical Decision Support Systems for Sepsis Market Revolutionary Primer for Clinical Decision Support (Market Dynamics, Case Studies, Regional Analysis (North America, Europe, Asia Pacific, Rest of the World)) – Global Forecast to 2022″, The MDSS for Sepsis Market is expected to reach USD 35.6 Million, at a CAGR of 24.3%.Increasing funding & research grants, growing pressure to curb healthcare spending, and improving patient outcomes are the major factors propelling the growth of the market.In addition, machine learning & artificial intelligence in CDSS is posing as a lucrative opportunity for the market in the coming years.Various players in the market offer sepsis CDS solutions embedded in their EHR while there are others who offer separate surveillance solutions for sepsis.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=227232851Objectives of the Study:– To define, describe, and forecast the global medical decision support systems for sepsis market on the basis of region– To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)– To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market– To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders– To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the WorldGeographically, the North American market accounted for the largest share in 2017 and is expected to register the highest CAGR during the forecast period.The large share and high growth can be attributed to factors such as increasing efforts to curb healthcare spending, federal initiatives such as the Hospital Readmissions Reduction Program, and rising investments in HCIT solutions in the country.Major players providing sepsis CDS modules include Cerner, Epic, and MEDITECH.Third-party vendors like VigiLanz, Iatric Systems, and PeraHealth are also based out of the US.The presence of these key players in the country has made the US a center of innovation in the CDSS market.
1
The report “North American Radiation Protection Apron Market by Type (Front Protection, Vest and Skirt, Pregnancy Lead Apron), Material (Lead Aprons, Lead-Free Apron, Light Lead Composite Apron), Country (US, Canada) – North America – Forecast to 2024″, the radiation protection aprons market is projected to reach USD 49 million by 2024 from USD 36 million in 2019, at a CAGR of 6.6%.The Growth is driven by the increasing safety awareness among people working in radiation-prone environments, growth in the number of trained radiologic technologists, growing number of orthopedic and spine surgeries, and the increasing prevalence of cancer.On the other hand, discomfort and pain due to the heavy weight of lead aprons is expected to hamper the growth of this market during the forecast period.North American Radiation Protection Aprons Market Recent Developments:In 2019, Infab Corporation (US) received certification from Perry Johnson Registrars, Inc., an accredited certification body, to design and develop radiation protective apparel, accessories, barriers, apron racks, and gloves.In 2018, Infab Corporation (US) announced that it would launch its revolution premium vest and skirts with interior pockets in January 2019.In 2018, Infab Corporation (US) expanded its revolution aprons with the latest revolution color—light blue serenity.Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=124332526Front protection aprons segment accounted for the largest share of the North American medical radiation protection aprons market in 2018.Based on type, segmented into front protection aprons, vest and skirt aprons, and other aprons.In 2018, the front protection aprons segment accounted for the largest market share primarily due to the wide availability and high usage of these aprons in dental clinics and hospital settings.Lead aprons segment accounted for the largest share of the North American medial radiation protection aprons market in 2018.Based on material, segmented into lead aprons, light lead composite aprons, and lead-free aprons.The lead aprons segment accounted for the largest share of the North American medial radiation protection aprons market in 2018.The large share of this segment is attributed to the durability of these aprons and their efficiency in blocking radiation and protecting the body.Geographical View in-detailed:“US to register the highest growth during the forecast period (2019–2024)”The North American medical radiation protection aprons market is segmented into the US and Canada.The US accounted for the largest share of the market in 2018 and is expected to witness the highest growth during the forecast period.
1
The report “Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) – Global Forecasts to 2024″, is projected to reach USD 35 million by 2024 from USD 24 million in 2019, at a CAGR of 7.4%The growing global prevalence of lymphedema and cancer; technological advancements in diagnostic imaging modalities; and increasing investments, funds, and grants by public-private organizations are the major factors driving the growth of this market.However, the high cost of diagnostic imaging systems, the short half-life of radiopharmaceuticals, the limited supply of helium, and the increasing adoption of refurbished diagnostic imaging systems are expected to restrain the growth of this market.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=145177203Market Segmentation in Detailed:The lymphoscintigraphy segment accounted for the largest share of the lymphedema diagnostics market in 2018.Based on technology, segmented into lymphoscintigraphy, magnetic resonance imaging (MRI), ultrasound imaging, computed tomography (CT), X-ray lymphography, bioimpedance analysis, and near-infrared fluorescence imaging.In 2018, the lymphoscintigraphy segment accounted for the largest share of the market.The noninvasive nature and easy reproducibility of this technology, and the fact that lymphoscintigraphy does not adversely affect the lymphatic vascular endothelium are some of the key advantages supporting the adoption of this technology.The cancer segment accounted for the largest share of the lymphedema diagnostics market in 2018.On the basis of disease type, segmented into cancer, inflammatory diseases, cardiovascular disease, and other diseases (congenital abnormalities, trauma-related conditions, infections, and filariasis).The cancer segment accounted for the largest share of the market in 2018.The large share of this segment can be attributed to the rising prevalence of cancer-associated lymphedema and increasing awareness about early disease diagnosis.Geographical View in-detailed:The lymphedema diagnostics therapy market is segmented into four regional segments, namely, North America, Europe, the Asia Pacific, and the Rest of the World.
1
The report “Laboratory Gas Generators Market by type (Nitrogen, Hydrogen, Zero Air, Purge Gas, ToC), Application (Gas Chromatography, LC-MS), End user (Life Science Industry, Chemical & Petrochemical Industry, Food & Beverage Industry) – Global Forecast to 2026″, the global lab gas generators market is projected to reach USD 686 million by 2026 from USD 353 million in 2021, at a CAGR of 14.2% during the forecast period.The growth of the laboratory gas generators market is primarily driven by the growing importance of analytical techniques in drug and food approval processes, rising food safety concerns, increasing adoption of laboratory gas generators owing to their various advantages over conventional gas cylinders, growing demand for hydrogen gas as an alternative to helium, and the increasing R spending in target industries.GROWTH OPPORTUNITY: Opportunities in the life sciences industry;The demand for the analytical testing of cannabis for ensuring its safety before human consumption has increased in recent years, as medical cannabis is being legalized in a number of countries/states across the globe.Medical cannabis has proven effective in various medical applications, such as reducing nausea caused due to chemotherapy, stimulating appetite in AIDS patients, controlling muscular spasms in multiple sclerosis patients, and reducing intraocular pressure in patients with glaucoma.Owing to their health benefits, governments in various countries are legalizing the use of medical cannabis.Australia (2016), Canada (2015), South Korea (2018), Portugal (2001), the UK (2006), Germany (2017), Italy (2013), the Netherlands (2003), and Brazil (2017) have all legalized the use of medical cannabis in recent years.Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=133302129Nitrogen gas generators accounted for the larger share of the share of global lab gas generators market in 2020Based on type, segmented into nitrogen gas generators, hydrogen gas generators, zero air generators, purge gas generators, TOC gas generators, and other gas generators.The nitrogen gas generators segment accounted for the largest share of global laboratory gas generators market.This can be attributed to factors such as cost-efficiency, increased safety, reduced downtime and supply issues, environmental benefits, and its wide usage among end users.The liquid chromatography-mass spectrometry (LC-MS) segment accounted for the largest market share in 2020Based on application, segmented into gas chromatography (GC), liquid chromatography-mass spectrometry (LC-MS), gas analyzers, and other applications.
1
The “Track and Trace Solutions Market by Product (Plant Manager, Checkweigher, Barcode Scanner, Monitoring), Technology (2D Barcode, RFID), Application (Serialization, Aggregation, Reporting), End User (Pharma, Food, Medical Devices) – Global Forecast to 2026″, is projected to reach USD 7.3 billion by 2026 from USD 4.1 billion in 2021, at a CAGR of 12.1% during the forecast period.COVID-19 Impact on the Track and Trace Solutions Market;COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus.Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a matter of a few weeks.The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020.Since the beginning of 2020, most countries worldwide shut down their borders and limited transportation in a bid to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation.This disrupted the supply chains for the track and trace market, temporarily leading to a fall in demand due to uncertainty in the global economy and capital markets.We estimate that the major share of the medical device industry, which includes imaging devices, dental care devices, and surgical products, contributes 60–75% of the overall medical devices market.A new USD-5–7 billion market opportunity (by 2021) is opening up in the medical devices industry, including critical care medical devices.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=158898570“The 2D Barcode segment accounted for the largest market share in 2020.”Based on technology, the track and trace solutions market is segmented into linear barcodes, 2D barcodes, and radiofrequency identification (RFID).
1
The report “Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India, China) – Forecast to 2025″, size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.The Factors such as the increasing diabetic population, rising awareness of diabetes treatment and management, and favorable national health strategies are expected to drive the growth of the diabetes care devices (BRIC) market.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=375The blood glucose monitoring systems segment is estimated to dominate the diabetes care devices market in 2020Based on type, segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications.Under the blood glucose monitoring systems segment, the test strips segment is estimated to account for the largest share in 2020.The dominance of this segment can be attributed to the frequent requirement of test strips in blood glucose monitoring systems.The self/home healthcare is projected to witness the highest CAGR in the diabetes care devices (BRIC) market during the forecast periodBased on end user, segmented into hospitals & specialty clinics and self/home healthcare.The self/home healthcare segment is estimated to hold the largest share in 2020.This segment is also projected to grow at the highest CAGR during the forecast period.The rapid growth of the segment is attributed to the increasing awareness of diabetes self-monitoring and management, increasing recommendations from physicians for home healthcare for diabetes, and the increasing utility of home-based diabetes care devices to provide real-time insights regarding the condition due to the technological advancements of these systems.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375Geographical View in-detailed:China held the largest share in the diabetes care devices (BRIC) market in 2019.
The report “Flexible and Semi-rigid Ureteroscopy Market by Product (Flexible Ureteroscopes, Semi-rigid Ureteroscopes), Application (Urolithiasis, Urinary Stricture, Kidney Cancer), End User (ASCS, Hospitals), and Region (US, Canada, Asia, Europe) – Global Forecast “, the flexible ureteroscopy market is expected to reach USD 1,054.1 million, at a CAGR of 5.4%.The high incidence of urolithiasis across the globe is a major factor driving the growth of this market.The rapidly increasing geriatric population, technological advancements in devices, and improving hospital infrastructures are the other major factors that are expected to support the growth of the semi-rigid ureteroscopy market in the coming years.The Objectives of this Study are as follows:To define, describe, and forecast the flexible & semi-rigid ureteroscopy market by product type, application, end user, and regionTo forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)To identify the micromarkets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the marketTo analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall marketRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=253934795Market Segmentation in Detailed:Flexible ureteroscopes are expected to account for the largest share of the marketBy type of product, the flexible & semi-rigid ureteroscopes market is further segmented into flexible and semi-rigid ureteroscopes.The growing incidence of urolithiasis, rising prevalence rate of kidney cancers, and technological advancements in flexible ureteroscopes are the primary factors driving the growth of the flexible ureteroscopy market.The digital ureteroscopes segment is expected to account for the larger market share in 2018 owing to the higher efficacy and better image output of these devices.Hospitals are expected to dominate the flexible & semi-rigid ureteroscopy end-user market in 2018By end user, ureteroscopy market is segmented into hospitals, ambulatory surgical centers, and other end users.This large share can be attributed to the high number of surgeries performed in hospitals.Geographical View in-detailed:The is geographically classified into North America, Europe, Asia, and the Rest of the World (RoW).North America is the largest regional market for ureteroscopes majorly due to the high prevalence of kidney stones (and the large number of surgical procedures performed for the same) and the rising healthcare expenditure in this region.
2
The report “Bone Growth Stimulators Market by Product (Device, Bone morphogenetic protein, PRP), Application (spinal fusion, Delayed Union & Non Union Bone Fracture, Dental, Maxillofacial), End User (Hospitals, Home care, Academia, CROs) – Global Forecast”, is expected to reach USD 1.41 billion, growing at a CAGR of 5.4%.Procedural benefits offered by bone stimulation devices in bone fracture treatment;Bone growth stimulation devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures.This is expected to aid the adoption of bone growth stimulation products among key end users.This is also augmented by clinical evidence that validates the clinical efficacy of bone growth stimulation products in the effective and rapid bone regeneration as compared to traditional methodologies.As of 2015, the average treatment cost saving for diabetes patients in the U.S. being treated with electrical bone growth stimulation (EBGS) devices was reported to be ~USD 4,800 and USD 3,000 as compared to non-stimulation based treatment and low-intensity pulsed Ultrasound stimulation (LIPUS) treatment, respectively (Source: Journal of Diabetes & Metabolism, 2013).Similarly, a research study was undertaken among adult patients diagnosed with a nonunion bone fracture between July 2006 and September 2009 in the U.S.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=82341383The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this market.However, limited medical reimbursement for bone stimulation products and high treatment costs associated with BMP and PRP products may hinder the growth of this market during the forecast period.Market Segmentation in Detailed:On the basis of product, the global bone growth stimulators market is segmented into bone growth stimulation devices, bone morphogenetic protein (BMPs), and platelet-rich plasma (PRP).The bone growth stimulation devices segment accounted for the largest share of the market in 2016.
1
The report “Particle Counters Market by Type (Airborne, Liquid), Application (Cleanroom Monitoring, Contamination Monitoring of Liquids, IAQM), End User (Life Sciences & Medical Devices, Semiconductor, Automotive), Region – Global Forecast to 2025″, is projected to grow at a CAGR of 9.9% during the forecast period, to reach USD 554 million by 2025 from USD 346 million in 2020.The Market growth is driven largely by factors, such as robust growth in applied markets, the favorable regulatory scenario, and growing focus on the quality of food products are the key factors driving the growth of the particle counter market.In addition, emerging economies (such as Brazil, India, South Korea, and China).COVID-19 Impact on the Global Particle Counters Market;The COVID-19 pandemic has intensified drug discovery and research efforts while adding to the pressure on pharma and clinical labs.Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is still diverse.While a few industries will register a drop in demand, numerous others will continue to remain stable and show promising growth opportunities.The particle counters market has witnessed significant growth over the years; however, due to the unexpected COVID-19 outbreak, the market is expected to witness a mixed set of market adoption in 2020, owing to their increasing usage in drug development, pharma-biopharma manufacturing, and medical device manufacturing.However, several allied industrial application of target products are reported with limited utilization of particle counters due to supply chain disruptions in the aerospace and automobile industries, and regulatory relaxation to pollution monitoring & bulk manufactutring industries.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=221564539Cleanroom monitoring segment accounted for the largest share of the particle counters applications market in 2019The cleanroom monitoring segment accounted for the largest share of the particle counters market, by application, in 2019.Technological advancements in industries such as pharmaceutical, medical devices, automotive, and aerospace are increasing the demand for quality assurance and stringent regulations of manufacturing environments to ensure product quality.
The study involved four major activities to estimate the current size of the orthopedic braces and supports market.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Top-down and bottom-up approaches were employed to estimate the complete market size.The report “Orthopedic Braces and Supports Market by Product (Knee, Ankle, Hip, Spine, Shoulder, Neck, Elbow, Hand, Wrist), Category (Soft, Hard, Hinged), Application (Ligament (ACL, LCL), Preventive, OA), Distribution (Hospital) & Region – Global Forecast to 2025″, the global orthopedic braces market size is estimated to be USD 3.1 billion in 2020 and projected to reach USD 4.1 billion by 2025, at a CAGR of 5.8 %.Opportunity: Increased sales of off-the-shelf and online products;Specific orthopedic braces can only be used under the supervision of medical practitioners or orthopedic technicians as they require customization or product alternation according to patient features.However, some braces (such as ankle braces, wrist/hand braces, shoulder braces, elbow braces, and facial braces) are increasingly being sold through retailers (off-the-shelf), and e-commerce websites since their use do not require an authorization from medical professionals.Patients regularly use such products as preventive measures to avoid injuries.BraceAbility (US), Amazon.com (US), and Alibaba.com (China) are common e-commerce websites selling orthopedic products.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=24806829Market Segmentation in Detailed:Demand for knee braces and supports among medical professionals and athletes is expected to result in the segment occupying the majority of the orthopedic braces and supports market share;The knee braces and supports market is estimated to have the largest market share by value.
1
The report “Thyroid Function Test Market by Type (TSH Tests, T4 Tests, T3 Tests), End User (Hospitals, Diagnostic Laboratories, Research Laboratories & Institutes), and Region (North America, Europe, APAC, LATAM, and MEA) – Global Forecast”, is expected to reach USD 1.68 Billion, at a CAGR of 5.9%.The Factors such as increasing incidence of thyroid disorders, awareness about thyroid disorders, prevalence of lifestyle diseases, rising geriatric population, and increasing consumption of alcohol and tobacco are driving the growth of the market.Research Methodology:Both, top-down and bottom-up approaches were used to estimate and validate the size of the global market and to estimate the size of various other dependent submarkets in the overall thyroid function test industry.Various secondary sources, such as associations like American Thyroid Association, British Thyroid Foundation, American Association for Clinical Chemistry, European Thyroid Association (ETA), Asia & Oceania Thyroid Association, Asia-Pacific Society of Thyroid Surgery, Latin American Thyroid Society, directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market.Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=85085049The TSH tests segment is expected to account for the largest share of the market.On the basis of type, the market is segmented into TSH tests, T4 tests, T3 tests, and other tests.In 2017, the TSH tests segment is estimated to account for the largest share of the thyroid function tests market.The large share rate of this segment can be attributed to the fact that TSH tests are initially prescribed by physicians to majority of patients (for the assessment of thyroid gland functioning) showing symptoms of thyroid disorders.The hospitals segment is expected to account for the largest share of the market.Based on end users, broadly segmented into hospitals, diagnostic laboratories, research laboratories and institutes, and other end users.The hospitals segment is estimated to account for the largest share of the global thyroid function tests market in 2017.
2
The Research Report on “Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) – Global Forecast” published by MarketsandMarkets™, the market witnessed healthy growth during the last decade and poised to grow at a CAGR of 12.3%, to reach USD 573.0 Million.The Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R investments in life sciences industry.Increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this market.Don’t miss out on business opportunities in “Viral Inactivation Market”.Speak to Our Analyst and gain crucial industry insights that will help your business growth:https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=121427017Viral Inactivation Market Segmentation in Detailed:Based on end user, categorized into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users.Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.The application segments included in the report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.Based on geography the market is segmented into North America, Europe, Asia and Rest of the World (RoW).Rapidly increasing pharmaceutical and biotechnology industries and increasing number of new biologics products launched will be the two most important growth drivers for this market in the forecasted period (2016-2021).
1
The report “Women’s Health Care Market by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Primarin, Actonel), Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, PCOS, Menopause) – Global forecast to 2024″, is projected to reach USD 17.8 billion by 2024 from USD 9.6 billion in 2019, at a CAGR of 13.2% during the forecast period.The Market growth is largely driven by the growing incidence of chronic health conditions among women, government initiatives to curb population growth, growing demand for contraceptives to prevent unintended pregnancies, and the growing focus on R by key players for the development of advanced products.On the other hand, the reluctance to use contraceptives is a major factor limiting the market growth.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=136585329Prolia is the largest and fastest-growing segment of the market.Based on drug, the women’s healthcare market is segmented into EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, FORTEO, Premarin, ACTONEL, and ORTHO-TRI-CY LO (28).Prolia has witnessed positive market growth owing to the increasing prevalence of postmenopausal osteoporosis in the US.The postmenopausal osteoporosis segment is expected to grow at the highest CAGR during the forecast period.On the basis of application, the women’s healthcare market is segmented into hormonal infertility, postmenopausal osteoporosis, endometriosis, contraceptives, menopause, PCOS, and other applications.The postmenopausal osteoporosis segment is expected to grow at a higher CAGR during the forecast period.Furthermore, the focus of pharmaceutical players on providing effective drugs for postmenopausal osteoporosis also supports the growth of this segment.The postmenopausal osteoporosis segment also holds the largest share of the market owing to these factors.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136585329North America accounted for the largest share of the women’s health care market in 2019.The global women’s healthcare market is segmented into five major regions, namely, North America, Europe, APAC, Latin America, and the Middle East & Africa.
1
The report “Lancets Market by Type (Safety Lancets (Push button, Pressure Activated, Side Button), Personal Lancets), Application (Glucose Testing, Hemoglobin Testing), End User (Hospital, Clinic, Homecare), Region – Global Forecast to 2024″, the lancing devices market is projected to grow at a CAGR of 12.4% during the forecast period to reach USD 1,442 million by 2024 from USD 804 million in 2019.The Growth in the lancets market is mainly driven by the growing prevalence of diabetes and the high prevalence of infectious diseases across the globe.In addition, emerging markets such as India and China are expected to offer growth opportunities for players operating in the market during the forecast period.However, the risk of needlestick injuries, the reuse of lancets, and the poor reimbursement scenario in developing countries are restricting the growth of this market.Recent DevelopmentsIn 2018, HTL-STREFA expanded its storage capacity in Leczyca by almost 50%, with an equivalent of 3,550 m2 additional storage space.In 2018, HTL-STREFA was acquired by Investindustrial.This acquisition helped the companies partner for diabetes management, thus serving an extensive customer base.In 2017, Owen Mumford opened its new facility in Malaysia to strengthen and accelerate the growth of the company in the Asia Pacific region.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=86063487The Safety Lancet is expected to be the most widely used type of the lancets marketThe safety lancets accounted for the largest market share in 2018.This is primarily be attributed to the advantages associated with safety lancets such as their ease of use, the capability to prevent needlestick injuries and cross-contamination, and painlessness of vein puncture.This is expected to increase the demand of safety lancets.The Glucose testing segment is expected to account for the largest share of the lancets market applicationThe glucose testing segment accounted for the largest share of the lancing devices market, by application, in 2018.
The report “Synthetic Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America (US, Canada}, Europe, APAC, RoW) – Global Forecast to 2028″, the artificial stem cells market size is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast period.The study involved four major activities in estimating the current market size for synthetic stem cells.Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.The top-down approach was employed to estimate the complete market size.Market Size Estimation;The top-down approach was used to estimate and validate the total size of the synthetic stem cells market.The approach was also used extensively to estimate the size of various sub-segments in the market.The research methodology used to estimate the market size includes the following:Synthetic stem cells that could be used as therapy were identified through secondary research, and their market shares in the respective segments were determined through primary and secondary research.The procedure included extensive interviews with industry leaders such as CEOs, VPs, directors, and marketing executives for key insights.All percentage shares, splits, and breakdowns were determined using secondary sources and are verified through primary sources.All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=4959435The cardiovascular diseases segment is expected to command the largest share of the overall synthetic stem cells market during the forecast period.The Artificial stem cells market, by application, is estimated to be dominated by the cardiovascular diseases segment in 2023.
1
More

Top